Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Uncover effective ways to increase points on credit cards and watch your rewards grow. Start optimizing your spending today.
18,895 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
A high-profile Texas ruling removed Roc Nation from a cluster of lawsuits linked to a celebrity legal fight. This art...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
Nasdaq’s CFO argues that AI is a leadership issue, not a back-office project. With 650 institutions using its AI-powe...
Midweek market news can move fast. This Wednesday reads guide curates clear, actionable investing ideas—from AI hype ...
A surge in viral public whale liquidations on Hyperliquid is turning whale activity into a real-time trading signal, ...
The AI boom has put semiconductors in the spotlight. This guide breaks down the AMD vs Intel debate, offering a clear...
General Motors stock surged 65% in the last year, leaving investors wondering if the rally has legs. This article cut...
NVIDIA’s edge in AI infrastructure goes beyond silicon speed. The real reason Nvidia holds its monopoly is a tightly ...
In stock market today, june, BlackBerry delivered a powerful earnings beat that sparked a rally in its shares. This p...
Could oil trend toward $60 a barrel by 2027? This article analyzes the scenario, the forces at play, and concrete sto...